Screening for Cytotoxic Compounds in Poor-prognostic Chronic Lymphocytic Leukemia
Anticancer Research, 07/27/2012
Norberg M et al. – Using primary cultures of cells from high–risk chronic lymphocytic leukemia (CLL) patients for compound screening is a feasible approach and that 5–azacytidine and orlistat exemplify substances that exhibit cytotoxicity in poor–risk CLL.



